RadNet, Inc. (RDNT): Long-Term Debt
$1.09B
As of 2025-12-31
$1.33B
As of 2026-06-30
+8.6%
3-year compound annual growth
+10.8%
5-year compound annual growth
+6.0%
10-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $1.09B | +7.2% | 2026-03-02, Balance as of period end |
| 2024-12-31 | $1.02B | +22.4% | 2026-03-02, Balance as of period end |
| 2023-12-31 | $830.04M | -2.5% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $851.74M | +12.9% | 2024-02-29, Balance as of period end |
| 2021-12-31 | $754.66M | +15.6% | 2023-03-01, Balance as of period end |
| 2020-12-31 | $652.70M | n/a | 2022-03-01, Balance as of period end |
| No annual figure between 2017-12-31 and 2020-12-31. | |||
| 2017-12-31 | $575.04M | -6.1% | 2018-03-19, Balance as of period end |
| 2016-12-31 | $612.17M | +0.8% | 2018-03-19, Balance as of period end |
| 2015-12-31 | $607.61M | +6.1% | 2017-03-17, Balance as of period end |
| 2014-12-31 | $572.50M | -0.5% | 2016-03-15, Balance as of period end |
| 2013-12-31 | $575.45M | +0.3% | 2015-03-16, Balance as of period end |
| 2012-12-31 | $573.76M | n/c | 2014-03-17, Balance as of period end |
| 2011-12-31 | $555.96M | n/a | 2013-03-18, Balance as of period end |
Long-Term Debt at similar companies
| Company | Year ended | Long-Term Debt | Change YoY |
|---|---|---|---|
| RadNet, Inc. (RDNT) | 2025-12-31 | $1.09B | +7.2% |
| Guardant Health, Inc. (GH) | 2025-12-31 | $1.50B | +31.6% |
| Caris Life Sciences, Inc. (CAI) | 2025-12-31 | $378.45M | +1.4% |
| Quest Diagnostics Inc (DGX) | 2025-12-31 | $5.67B | -8.8% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $10.06M | +0.3% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $57.23M | +11.2% |
| Biodesix Inc (BDSX) | 2025-12-31 | $50.01M | +24.9% |
| Exagen Inc. (XGN) | 2025-12-31 | $22.91M | +13.1% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $17.40M | -14.8% |
Compare RDNT, GH, CAI, DGX side by side · Screen every company in Services-Medical Laboratories ↗